Candel Therapeutics Inc
CADL
NASDAQ
Biotechnology
$11.72
USD
-0.08 (-0.68%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $864.59M
Volume 2.1M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
CADL | Candel Therapeutics Inc | $864.59M | - | - | - | |
XGN | Exagen Inc | $159.21M | - | +20.8% | - | |
ANIX | Anixa Biosciences Inc | $109.89M | - | - | - | |
COYA | Coya Therapeutics Inc | $109.55M | - | +115.4% | - | |
FBIO | Fortress Biotech Inc | $96.00M | 0.75 | +14.5% | +0.5% | |
GANX | Gain Therapeutics Inc | $94.49M | - | - | - | |
INO | Inovio Pharmaceuticals Inc | $93.07M | - | - | - | |
BMEA | Biomea Fusion Inc | $92.78M | - | - | - |
Top Peer by Growth
Coya Therapeutics Inc
+115.4% YoY Revenue
Lowest P/E Ratio
Fortress Biotech Inc
0.75x P/E
Best 1-Year Return
Candel Therapeutics Inc
+68.2% Return